title: Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle.
abstract: Human airway epithelial cells grown to confluence were incubated with varying concentrations (10-100 microM) of arachidonic acid or platelet activating factor (PAF) for periods of 30 min to 24 h. Both stimuli caused the production of 15-hydroxyeicosatetraenoic acid (15-HETE) by epithelial cells as determined by HPLC. Neither stimulus caused the production of leukotrienes, thromboxane or prostaglandins aside from minimal amounts of PGE2. Maximal production of 15-HETE after arachidonic acid (10 microM; N = 9) occurred at 1 h (235 +/- 59 ng/mg protein), whereas maximum generation after PAF treatment (10 microM; N = 9) occurred at 6 h (153 +/- 48 ng/mg protein). Neither arachidonic acid nor PAF at concentrations up to 100 microM caused cell toxicity as determined by 51Cr release. 15-HETE at concentrations of greater than or equal to 0.1 microM contracted isolated human bronchus. An initial small amplitude, short-lasting (less than 15 min) contraction was followed by a much larger contraction beginning 30-60 min following 15-HETE challenge, reaching a maximum at approximately 2 hr. These results demonstrate that PAF may induce delayed airway smooth muscle contraction by the generation of 15-HETE from epithelial cells. The kinetics of 15-HETE generation and its contractile activity are compatible with it being a mediator of the late asthmatic reaction.
authors.affiliation: Department of Medicine, University of British Columbia, Vancouver, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Salari
authors.forename: R R
authors.initials: RR
authors.lastname: Schellenberg
mesh_terms: D016718:Arachidonic Acid / Q000378:metabolism / Q000494:pharmacology*; D001980:Bronchi / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000096:biosynthesis*; D066298:In Vitro Techniques; D007700:Kinetics; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009126:Muscle Relaxation / Q000187:drug effects / Q000502:physiology; D009130:Muscle, Smooth / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014176:Protein Biosynthesis; D013268:Stimulation, Chemical
chemical_list: D006893:Hydroxyeicosatetraenoic Acids; D010972:Platelet Activating Factor; D016718:Arachidonic Acid; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid